Deborah Sanders
Overview
Explore the profile of Deborah Sanders including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martins F, Couturier D, de Santiago I, Sauer C, Vias M, Angelova M, et al.
Nat Commun
. 2022 Oct;
13(1):6360.
PMID: 36289203
Chromosomal instability is a major challenge to patient stratification and targeted drug development for high-grade serous ovarian carcinoma (HGSOC). Here we show that somatic copy number alterations (SCNAs) in frequently...
2.
Sim G, Martin-Orozco N, Jin L, Yang Y, Wu S, Washington E, et al.
J Clin Invest
. 2013 Dec;
124(1):99-110.
PMID: 24292706
High-dose (HD) IL-2 therapy in patients with cancer increases the general population of Tregs, which are positive for CD4, CD25, and the Treg-specific marker Foxp3. It is unknown whether specific...
3.
Hurley D, Araki H, Tamada Y, Dunmore B, Sanders D, Humphreys S, et al.
Nucleic Acids Res
. 2011 Nov;
40(6):2377-98.
PMID: 22121215
Gene regulatory networks inferred from RNA abundance data have generated significant interest, but despite this, gene network approaches are used infrequently and often require input from bioinformaticians. We have assembled...
4.
Araki H, Tamada Y, Imoto S, Dunmore B, Sanders D, Humphrey S, et al.
Angiogenesis
. 2009 Apr;
12(3):221-9.
PMID: 19357976
Fenofibrate is a synthetic ligand for the nuclear receptor peroxisome proliferator-activated receptor (PPAR) alpha and has been widely used in the treatment of metabolic disorders, especially hyperlipemia, due to its...
5.
Tamada Y, Araki H, Imoto S, Nagasaki M, Doi A, Nakanishi Y, et al.
Pac Symp Biocomput
. 2009 Feb;
:251-63.
PMID: 19209706
Some drugs affect secretion of secreted proteins (e.g. cytokines) released from target cells, but it remains unclear whether these proteins act in an autocrine manner and directly effect the cells...
6.
Imoto S, Tamada Y, Araki H, Yasuda K, Print C, Charnock-Jones S, et al.
Pac Symp Biocomput
. 2006 Nov;
:559-71.
PMID: 17094269
We propose a computational strategy for discovering gene networks affected by a chemical compound. Two kinds of DNA microarray data are assumed to be used: One dataset is short time-course...
7.
Ball C, Walker G, Harper P, Sanders D, McElligott M
Intensive Crit Care Nurs
. 2004 Apr;
20(2):62-8.
PMID: 15072773
The contribution nurses make to the management of critically ill patients is usually appraised through the use of concepts such as 'patient dependency' or 'nursing workload'. These concepts fail to...